T. I. Arefieva

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• Activated and regulatory T-helpers and blood monocytes in patients with HFPEF and type 2 diabetes mellitus2025
• Cardiometabolic Phenotype in HFpEF: Insights from Murine Models2025
• Cardiometabolic Phenotype in HFpEF: Insights from Murine Models2025
• Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives2024
• Association of lipoprotein(a) and remnant cholesterol with recurrent myocardial infarction in patients with premature CHD2024
• Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease2022 · аннотациясвернуть

  The detection of lipoprotein(a) [Lp(a)] in the artery wall at the stage of lipid-bands formation may indicate that it participates in the atherosclerosis local nonspecific inflammatory process. Innate immune cells are…

• The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis2021
• Immunotropic Effects and Proposed Mechanism of Action for 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors (Statins)2018 · аннотациясвернуть

  Inhibitors of HMG-CoA reductase (statins) are the major group of lipid-lowering drugs. Along with hypocholesterolemic activity, statins exhibit anti-inflammatory and immunomodulatory properties that expand their…